Health ❯ Metabolic Disorders

Obesity

Diabetes Type 2 Diabetes Treatment Animal Studies Weight Loss Pharmacological Advances Epigenetics Dental Health Genetics Treatment Options Cardiovascular Disease Diet-induced Obesity Hormonal Imbalance Gestational Diabetes Adipogenesis Comorbidities Drug Regulation Research Therapeutics Risk Factors Fatty Liver Disease

Berkeley Compound TOFA Cuts Fat in Obese Mice by Raising Energy Use

By increasing whole‑body energy expenditure, TOFA produced large fat loss in mice and could complement appetite‑reducing GLP‑1 drugs.

TOFA Boosts Fat Burning in Mice While Preserving Muscle

GLP-1 Drugs Reshape Obesity Care

Study Ties Obesity and Diabetes to Pancreatic Cancer via Six Inflammatory Genes

Advanced CKM Stages Linked to Higher Cancer Risk in Major Japanese Study

Studies Link GLP-1 Drugs to Lower Addiction and Overdose Risks

Lilly Combo of Zepbound and Taltz Tops Taltz Alone in Late-Stage Psoriasis Trials

Lilly and Nimbus Strike Multi-Year AI Deal for Oral Obesity Drugs

Prolynx Raises $70 Million to Advance Ultra-Long-Acting Obesity Drugs

Review Spotlights Senotherapeutics as Emerging Approach for Metabolic Disease

PNAS Study Identifies CHP1 as Master Regulator of Lipid Droplet Growth

Single CRISPR Treatment Lets Mice Produce Weight-Loss Drug for Over Six Months